Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antiretroviral therapy and the kidney: balancing benefit and risk in patients with HIV infection

Published:2006-02-27 Issue:2 Volume:5 Page:275-287
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Wyatt Christina M¹,Klotman Paul E²

Affiliation:

1. Instructor, Mount Sinai School of Medicine, Department of Medicine, Division of Nephrology, 1 Gustave L. Levy Place, New York, NY 10029, USA.

2. Chairman, Department of Medicine, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029, USA

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14740338.5.2.275

Reference138 articles.

1. UNAIDS: AIDS epidemic update 2003. Joint United Nations Programme on HIV/AIDS (UNAIDS) (2003).

2. Trends in Diseases Reported on U.S. Death Certificates That Mentioned HIV Infection, 1987–1999

3. Recent Progress in HIV-Associated Nephropathy

4. Highly Active Antiretroviral Therapy and the Epidemic of HIV+ End-Stage Renal Disease

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating glomerular filtration rate with new equations: can one size ever fit all?;Critical Reviews in Clinical Laboratory Sciences;2023-06

2. HIV positive patients on HAART continue to have a decline in renal function irrespective of Tenofovir usage: A 2-year cohort from an Indian tertiary care centre;2022-10-01

3. Drug-Induced Acute Kidney Injury;Critical Care Nephrology;2019

4. Acute kidney injury in HIV-infected patients: a critical review;HIV Medicine;2018-11-08

5. Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2018-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3